Royal Philips has received FDA 510(k) clearance for its Spectral CT Verida system, bringing the company’s AI-powered spectral CT technology to the U.S.
The system combines always-on spectral imaging with AI-based reconstruction to support clinical decision-making across applications, including cardiac and vascular imaging, according to an April 16 press release.
Verida uses a third-generation dual-layer detector with intrinsic noise reduction and a deep learning reconstruction engine to improve image clarity and allow clinicians to adjust de-noising. The system can reconstruct 145 images per second, deliver exams in less than 30 seconds and support up to 270 exams per day.
The platform enables access to conventional and spectral imaging data in a single scan, eliminating the need for repeat imaging.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
